Cite
HARVARD Citation
Oki, E. et al. (n.d.). 2137 Comparison of two Phase II trials of mFOLFOX6 plus bevacizumab (KSCC0802) and SOX (S-1 and oxaliplatin) plus cetuximab (KSCC1002): First line chemotherapy in colorectal cancer patients with initially unresectable or not optimally resectable liver only metastases. European journal of cancer. pp. S378-. [Online].